Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-10-05
1996-08-06
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
055434304
ABSTRACT:
A therapeutic mixture comprising a mixture of L-arginine and an agonist of nitric oxide synthase, namely nitroglycerin, is disclosed for the treatment of diseases related to vasoconstriction, wherein the vasoconstriction is relieved by stimulating the constitutive form of nitric oxide synthase (cNOS) to produce native nitric oxide (NO). The native NO having superior beneficial effect when compared to exogenous NO produced by a L-arginine independent pathway in terms of the ability to reduce clinical endpoints and mortality.
REFERENCES:
patent: 5132407 (1992-07-01), Stuehr et al.
patent: 5266594 (1993-11-01), Dawson et al.
patent: 5273875 (1993-12-01), Griffith et al.
patent: 5281627 (1994-01-01), Griffith et al.
patent: 5286739 (1994-02-01), Kilbourn et al.
A 118: 32771 (1992).
CA 121 54642 (1994).
Anderson, Todd J. et al. Nitric Oxide and Nitrovasodilators: Similarities, Differences and Potential Interactions. The American College of Cardiology. vol. 24, No. 2:555-566, 1994.
Sessa, William C. The Nitric Oxide Synthase Family of Proteins. J Vasc. Res. 31:131-143, 1994.
Drexler M. D., Helmut et al. Effect of L-Arginine on coronary Endothelial Function in Cardiac Transplant Recipients: Relation to Vessel Wall Morphology. Circulation. 89, 4:1615-1623, 1994.
Kumagai, Kazuhiro, et al. Nitric Oxide Increases Renal Blood Flow by Interacting With the Sympathetic Nervous System. Hypertension. 24, 2:220-226, 1994.
Quyyumi, Arshed A., et al. Effect of L-Arginine, the Substrate for Nitric Oxide, on Endothelium-Dependent Vasodilation of the Coronary Microvasculature. Journal Am. Coll. Cardiol; Abstracts. vol. 21, No. 2:151, 1993.
Faraci, PhD., Frank, et al. Nitric Oxide and the Cerebral Circulation. Progress Review. 692-702, 1993.
Kitamura, Yoshihiko. Nitric Oxide-Mediated Retinal Arteriolar and Arterial Dilation Induced by Substance P. Investigative Ophthalmology & Visual Science. 34, 10:2859-2865, 1993.
Dinerman, Jay L. et al. Molecular Mechanisms of Nitric Oxide Regulation: Potential Relevance to Cardiovascular Disease. Circulation Research. 73, 2:217-222, 1993.
De Garavilla, Lawrence, et al. Lack of Cross-Tolerance Between Nitroglycerin and Endothelium-Derived relaxing factor-mediated vasoactive agents in Spontaneously Hypertensive Rats. European Journal of Pharmacology. 234:77-82, 1993.
Weyrich, PhD., Andrew S., et al. The Role of L-Arginine in Ameliorating Reperfusion Injury After Myocardial Ischemia in the Cat. Circulation. vol. 86, No. 1:279-287, 1992.
Mayhan, William G., et al. Acetylcholine Induces Vasoconstriction in the Microcirculation of Cardiomyopathic Hamsters: Reversal by L-Arginine. Biochemical and Biophysical Research Communications. 184, 3:1372-1377, 1992.
Smith, Russell E. A., et al. Role of Nitric Oxide Synthesis in the Regulation of Coronary Vascular Tone in the Isolated Perfused Rabbit Heart. Cardiovascular Research. 26:508-512, 1992.
Dinerman, J. L. et al. Interactions Between Nitroglycerin and Endothelium in Vascular Smooth Muscle Relaxation. The American Physiological Society. H698-H701, 1991.
Richard, V., et al. The L-Arginine Nitric Oxide Pathway in the Canine Femoral Vascular Bed: In Vitro and In Vivo Experiments. Fundam Clin Pharmacol. 5:777-788, 1991.
Schror, Karsten, et al. Generation of Nitric Oxide from Organic Nitrovasodilators during Passage through the Coronary Vascular Bed and Its Role in Coronary Vasodilatoin and Nitrate Tolerance. Blood Vessels. 28:62-66, 1991.
Bennett, Brian M., et al. Relationship between Biotransformation of Glyceryl Trinitrate and Cyclic GMP Accuulation in Various Cultured Cells Lines. The Journal of Pharmacology and Experimental Therapuetics. 313-323 vol. 250, No. 1, 1980.
Ignarro, PhD., Louis J., et al. Pharmacology of Endothelium-Derived Nitric Oxide and Nitrovasodilators. Conferences and Reviews; West J Med. 154:51-62, 1991.
Drexler, Helmut, et al. Correction of Endothelial Dysfunciton in Coronary Microcirculation of Hypercholesterolaemic Patients by L-Arginine. The Lancet. 338:1546-1550, 1991.
Marletta, PhD., Michael A. Nitric Oxide, Nitrovasodilators, and L-Arginine--An Unusual Relationship. The Western Journal of Medicine. 154, 1:107-109, 1991.
Yang, Zhihong, et al. Endothelium-Derived Nitric Oxide in Human Arteries and Veins. Nitric Oxide from L-arginine: a bioregultory system. 89-93, 1990.
Vedernikov, Yuri P., et al. Endothelium-Derived Relaxing Factor is not Identical to Nitric Oxide. Nitric Oxide from L-arginine: a bioregultory system. 373-377, 1990.
Schroder, Henning, et al. Cross-Tolerance to L-Arginine-Dependent Guanylate Cyclase Activators in Nitrate-Tolerant LLC-PK.sub.1 Kidney Epithelial Cells. Pol. J. Pharmacol. Pharm. 42:259-263, 1990.
Palmer, R. M. J. et al. L-Arginine-Induced Hypotension. The Lancet. 696, 1990.
Gold, Michele E., et al. Depletion of Arterial L-Arginine Causes Reversible Tolerance to Endothelium-Dependent Relaxation. Biochemical and Biophysical Research Communications. 164, 2:714-721, 1989.
Palmer, D. S., R. M. J., et al. Vascular Endothelial Cells Synthesize Nitric Oxide from L-arginine. Nature. 333:664-666, 1988.
Flaherty, M. D., John T. Comparison of Intravenous Nitroglycerin and Sodium Nitroprusside in Acute Myocardial Infarction. The American Journal of Medicine. 53-60, 1983.
Bennett, Brian M., et al. Relationship between Biotransformation of Glyderyl Trinitrate and Cyclic GMP Accumulation in Various Cultured Cell Lines. The Journal of Pharmacology and Experimental Therapeutice. 250, 1:316-323, 1980.
Pituitary Function: Arginine Hydrochloride. American Hospital Form. Drug Inf. Directory. 36, 66:1418-1420, 1977.
Flaherty M. D., John T., et al. Intravenous Nitroglycerin in Acute Myocardial Infarction. Circulation. 51:132-139, 1975.
Feelisch, Martin et al. Biotransformation of Organic Nitrates to Nitric Oxide by Vascular Smooth Muscle and Endothelial Cells. Biochemical and bioPhysical Research Communications: Academic Press, Inc. vol. 180, No. 1:286-293. 1991.
Vasodilating Agents: Nitroglycerin. Am. Hosp. Frm. Drg. Inp. Dir. 24, 12:1033-1036. 1991.
Feelisch, Martin, et al. Biotransformation of Organic Nitrates To Nitric Oxide By Vascular Smooth Muscle and Enothelial Cells. Biochemical and Biophysical Research Communications. vol. 180, No. 1, pp. 286-293, 1991.
Flaherty, M. D., John T., Comparison of Intravenous Nitroglycerin and Sodium Nitroprusside in Acute Myocardial Infarction. The American Journal of Medicine. pp. 53-60, 1983.
Nakanishi, Katsuhiko, et al. Intracoronary L-arginine during Reperfusion Improves Endothelial Function and Reduces Infarct Size. The American Physiological Society, H1650-H1658, 1992.
Feelisch, M., Biotransformation to Nitric Oxide of Organic Nitrates in Comparison to Other Nitrovasodilators. The European Society of Cardiology. European Heart Journal, (1993), (Supplement I). pp. 123-132.
LandOfFree
Method and formulation of stimulating nitric oxide synthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and formulation of stimulating nitric oxide synthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and formulation of stimulating nitric oxide synthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191321